Novartis(NVS)
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and
Cambridge, Massachusetts, United States (global research). It is one of the largest pharmaceutical companies in the world.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
Mock data
Subscribe for the real data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Acylanid | Acetyldigitoxin | 1982-01-01 | — | |
| Adakveo | Crizanlizumab | 2019-11-15 | ||
| Afinitor | Everolimus | 2009-03-30 | 2025-2028 | |
| Afinitor disperz | Everolimus | 2012-08-29 | 2025-2028 | |
| Aimovig | Erenumab | 2018-07-26 | ||
| Alomide | Lodoxamide tromethamine | 1993-09-23 | ||
| Amturnide | Aliskiren, Amlodipine besylate, Hydrochlorothiazide | 2010-12-21 | 2023-2029 | |
| Antrenyl | Oxyphenonium | 1982-01-01 | — | |
| Anturane | Sulfinpyrazone | 1982-01-01 | ||
| Apresazide | Hydralazine, Hydrochlorothiazide | 1982-01-01 | 2023-2028 | |
| Apresoline | Hydralazine | 1982-01-01 |
1
2
3
4
5
6
...
19
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
27
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use